Clinical Trial

An Exploratory Study of ctDNA-MRD in Predicting the Efficacy of Esophageal Squamous Cell Carcinoma

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 8, 2023 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to observe and evaluate the correlation between ctDNA-MRD and the therapeutic effect and prognosis of stage II-IVA operable esophageal squamous cell carcinoma.
Trial Details
NCT Number NCT05759325
Lead Sponsor Guangzhou Institute of Respiratory Disease
Conditions Squamous Cell Carcinoma of Esophagus
Enrollment 100 participants
Start Date 2023-03
Primary Completion 2026-03 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2023-03-08